Lily Li

Lily Li

Auto-generated profile, based on publicly available information

Lily Li

Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Boston, Mass; Department of Medicine, Harvard Medical School, Boston, Mass

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2020 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
JKJune-Ho Kim
June-Ho Kim
DFDanielle R. Fine
Danielle R. Fine
LLLily Li
Lily Li
SKSimeon D. Kimmel
Simeon D. Kimmel
LNLong H. Ngo
Long H. Ngo
SHShoshana J. Herzig
Shoshana J. Herzig
Patients with opioid use disorder (OUD) who are hospitalized for serious infections requiring prolonged intravenous antibiotics may face barriers to discharge, which could prolong hospital length of stay (LOS) and increase financial burden. We investigated differences in LOS, discharge disposition, and charges between hospitalizations for serious infections in patients with and without OUD. We utilized the 2016 National Inpatient Sample—a nationally representative database of all discharges from US acute care hospitals. The population of interest was all hospitalizations for infective endocarditis, epidural abscess, septic arthritis, or osteomyelitis. The exposure was OUD, and the primary outcome was LOS until discharge, assessed by using a competing risks analysis to estimate adjusted hazard ratios (aHRs). Adjusted odds ratio (aOR) of discharge disposition and adjusted differences in hospital charges were also reported. Of 95,470 estimated hospitalizations for serious infections (infective endocarditis, epidural abscess, septic arthritis, and osteomyelitis), the mean age was 49 years and 35% were female. 46% had Medicare (government-based insurance coverage for people age 65+ years), and 70% were non-Hispanic white. After adjustment for potential confounders, OUD was associated with a lower probability of discharge at any given LOS (aHR 0.61; 95% CI 0.59–0.63; p < 0.001). OUD was also associated with lower odds of discharge to home (aOR 0.38; 95% CI 0.33–0.43; p < 0.001) and higher odds of discharge to a post-acute care facility (aOR 1.85; 95% CI 1.57–2.17; p < 0.001) or patient-directed discharge (also referred to as “discharge against medical advice”) (aOR 3.47; 95% CI 2.80–4.29; p < 0.001). There was no significant difference in average total hospital charges, though daily hospital charges were significantly lower for patients with OUD. Limitations include the potential for unmeasured confounders and the use of billing codes to identify cohorts. Our findings suggest that among hospitalizations for some serious infections, those involving patients with OUD were associated with longer LOS, higher odds of discharge to post-acute care facilities or patient-directed discharge, and similar total hospital charges, despite lower daily charges. These findings highlight opportunities to improve care for patients with OUD hospitalized with serious infections, and to reduce the growing associated costs.

17 November 2021 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
LLLily Li
Lily Li
JBJillian Bensko
Jillian Bensko
KBKathleen Buchheit
Kathleen Buchheit
RSRebecca R. Saff
Rebecca R. Saff
TLTanya M. Laidlaw
Tanya M. Laidlaw

9 September 2020 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
LLLily Li
Lily Li
YCYuchiao Chang
Yuchiao Chang
SSShuang Song
Shuang Song
ELElena Losina
Elena Losina
KCKaren H. Costenbader
Karen H. Costenbader
TLTanya M. Laidlaw
Tanya M. Laidlaw

1 November 2019 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
LLLily Li
Lily Li
TLTanya Laidlaw
Tanya Laidlaw

30 November 2023 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
LLLily Li
Lily Li
YCYuchiao Chang
Yuchiao Chang
NSNicole A. Smith
Nicole A. Smith
ELElena Losina
Elena Losina
KCKaren H. Costenbader
Karen H. Costenbader
TLTanya M. Laidlaw
Tanya M. Laidlaw

21 March 2023 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
LLLily Li
Lily Li
YCYuchiao Chang
Yuchiao Chang
ELElena Losina
Elena Losina
KCKaren H. Costenbader
Karen H. Costenbader
ACAntonia F. Chen
Antonia F. Chen
TLTanya M. Laidlaw
Tanya M. Laidlaw